Is the evidence-based medicine movement counter-productive: are randomised controlled trials the best approach to establish evidence in complex healthcare situations?
This paper examines the role of research that seeks to obtain evidence to support evidence-based medicine (EBM), using a case study of research into ear disease in Aboriginal populations, and suggested that in complex situations, perhaps randomised controlled trials are not the answer.
The Australian moratorium on genetics and life insurance: evaluating policy compared to Parliamentary recommendations regarding genetic discrimination
In 2018, a Parliamentary Joint Committee recommended an urgent ban be implemented on the use of predictive genetic test results in life insurance underwriting in Australia. This article evaluates whether the moratorium meets the Parliamentary Committee recommendations, and finds that it falls short in key...
Precision health: exploring opportunities and challenges to predict, prevent, diagnose, and treat disease more precisely in Aotearoa New Zealand
Precision health is an exciting and rapidly developing field that holds the potential to significantly improve the health and wellbeing of individuals, whānau and communities across Aotearoa. The Ministry of Health wants to hear about the opportunities and challenges that exist now and into the...
Shining a light: radiotherapy cancer treatment in Australia
This white paper highlights the most significant obstacles to accessing radiotherapy cancer care in Australia including access, awareness, and financial burden; and provides three evidence-based recommendations to improve utilisation of radiotherapy and health outcomes for Australians living with cancer.
Antimicrobial resistance: the silent global pandemic
Antimicrobial resistance is one of the most serious global public health threats of the 21st Century. This paper argues that now is the time for strong and sustained action on antimicrobial resistance, as this may well be the cause of the next global pandemic.
The roadmap to telehealth efficacy: care, health, and digital equities
In this paper, the authors propose flexibilities within the current health care system that accommodate the changes imposed by new technologies, as well as continued government incentives to drive more competitive options and alternatives for health care delivery.
Australia’s data-enabled research future: health and medical sciences
This report argues that in order to capitalise on the opportunities to improve health and make use of the ever-increasing volume of health data, Australia must develop an environment that enables the safe and secure use of patient data for legitimate research purposes – balanced...
The Australian Nuclear Science and Technology Organisation’s management of nuclear medicine assets
This audit examines the effectiveness of the Australian Nuclear Science and Technology Organisation’s management of assets involved in the manufacture, production and distribution of nuclear medicines.
Transforming the genomics workforce to sustain high value care
Genomics, where all a person’s genes are examined, as well as the interactions of those genes with each other, is proving a powerful tool for medicine. This report explores some of the challenges currently facing this rapidly evolving sector.
Research that matters: building health solutions
From vaccines to antibiotics, health and medical research has improved, extended, and saved lives. In this episode, Torrens University researchers talk about the need to build a new GP model of care for Australia’s rapidly ageing population.
National baseline report on Quality Use of Medicines and Medicines Safety - Phase 1: residential aged care
This report identifies a potential roadmap to embed Quality Use of Medicine principles in the aged care sector, with the aim of reducing medication-related harm.
The new frontier - delivering better health for all Australians
This report examines the opportunities to deliver better health care for Australians through our regulatory and health technology assessment process for both medicines and technologies.
Funding rare disease therapies in Australia: 2021 progress update
For the 2 million Australians living with rare diseases, access to medicines can be inadequate. This report reassesses 2014 research by the McKell Institute, assessing the state of rare disease therapies in Australia.
A systematic review of self-reported ethical practices in publications of cluster randomised trials conducted in Aboriginal and Torres Strait Islander settings
This systematic review describes self-reported ethical practices in research conducted in Australia involving Aboriginal and Torres Strait Islander people.
Australian Medical Association's vision for Australia's health
This strategy document represents a clear blueprint for all governments and players in Australia's health system, and is built around five pillars of detailed policy reform.
Medicare advanced imaging payment: dysfunctional policy making
This report outlines background information on U.S Medicare payment for imaging services in outpatient settings, followed by payment issues, trends and factors that make imaging payment policy difficult. It continues with an enumeration of recent policies designed to control Medicare spending on imaging, and offers...
Publishing at any cost: a cross-sectional study of the amount that medical researchers spend on open access publishing each year
This study aimed to estimate the financial costs paid by individual medical researchers from meeting the article processing charges (APCs) levied by open access journals in 2019.
Planning and governance of COVID-19 procurements to increase the National Medical Stockpile
This audit examined whether the COVID-19 National Medical Stockpile (NMS) procurement requirement was met through effective planning and governance arrangements.
Impact of COVID-19 on healthcare activity in NSW, Australia
COVID-19 has left no healthcare system untouched. The aim of this study was to quantify the changes in activity seen in the NSW health system in the first half of 2020.
Patient power: unleashing choice over routine medications
This report finds that many patients are not fully aware of the level of control they are entitled to when it comes to choosing medication. It suggests that pharmacists could play a greater role in the patient care pathway to support patients make choices about...
General Practice: health of the nation 2020
This report gives a unique overview of Australian general practice, while also addressing the impact of COVID-19 on general practice and patients.
Optimising healthcare through specialist referral reforms
The specialist referral system is a key operational component of the Australian health system. This briefing argues that moving towards a health service model that places a greater emphasis on the appropriateness of the referral above the profession of the referrer is necessary to bring...
Quality Use of Medicines and Medicines Safety discussion paper for public consultation – Phase 1: aged care
The Commission are developing a National Baseline Report on Quality Use of Medicines and Medicines Safety in response to this initiative. This discussion paper was published to support the public consultation which informed Phase 1 of the National Baseline Report.
Australian healthcare after COVID-19: an opportunity to think differently
Through this position paper, the Australian Healthcare and Hospitals Association argues that as Australia moves toward a post-COVID world, identifying the changes that are needed to form the foundation of a modern, sustainable and resilient healthcare system, focussed on health outcomes and capable of absorbing...
COVID-19 in the region: a quick guide
The impact of the COVID-19 pandemic across Australia’s immediate region is still unfolding. This guide represents a snapshot of the situation as at early June 2020.